Institutional Ownership
United Therapeutics Corp Del
CUSIP 91307C102COMUTHRQ1 2026
13D / 13G Filings
41
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
11.3%
Max % of class reported
Institutional Holders
838
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
41 filings · latest Feb 10, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 10, 2026 | Wellington Management Group LLP | 13G | 5.7% | 2.44M | SEC |
| 2 | May 12, 2025 | Wellington Management Group LLP | 13G/A | 4.5% | 2.03M | SEC |
| 3 | Feb 10, 2025 | Wellington Management Group LLP | 13G/A | 5.5% | 2.46M | SEC |
| 4 | Feb 5, 2025 | State Street Corporation | 13G | 4.9% | 2.20M | SEC |
| 5 | Nov 8, 2024 | Rothblatt Martine A | 13G/A | 6.8% | 3.19M | SEC |
| 6 | Oct 16, 2024 | State Street Corp | 13G | 5.0% | 2.24M | SEC |
| 7 | Jun 10, 2024 | Vanguard Group Inc | 13G/A | 10.6% | 4.69M | SEC |
| 8 | Feb 14, 2024 | Rothblatt Martine A | 13G/A | 7.8% | 3.90M | SEC |
| 9 | Feb 14, 2024 | Avoro Capital Advisors LLC | 13G/A | 6.1% | 2.86M | SEC |
| 10 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.9% | 4.67M | SEC |
31 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for United Therapeutics Corp Del.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 5.40M | $3.20B |
| 2 | Avoro Capital Advisors LLC | 2.63M | $1.56B |
| 3 | Wellington Management Group LLP | 2.26M | $1.34B |
| 4 | State Street Corp | 1.84M | $1.09B |
| 5 | Renaissance Technologies LLC | 1.79M | $1.06B |
| 6 | Geode Capital Management, LLC | 1.23M | $729.92M |
| 7 | Janus Henderson Group PLC | 866.9K | $514.02M |
| 8 | Aqr Capital Management LLC | 826.2K | $486.42M |
| 9 | Assetmark, Inc | 616.0K | $365.31M |
| 10 | Invesco Ltd. | 608.4K | $360.75M |